Form 4: RxSight Director Julie Andrews Reports Stock Transaction
Insider Transaction Report
Julie Andrews, a Director at RxSight, Inc., has reported a transaction involving the acquisition of 37,037 shares of common stock.
Summary
- Julie Andrews, a Director of RxSight, Inc., has filed a Form 4 reporting a transaction on June 17, 2026.
- The transaction involved the acquisition of 37,037 shares of common stock.
- Following this transaction, Ms. Andrews beneficially owns 78,076 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider stock acquisition without providing new financial or strategic information.
Positives
- Director Julie Andrews has acquired a significant number of shares, indicating continued confidence in the company.
- The acquisition of 37,037 shares increases her beneficial ownership to 78,076 shares.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. Such filings are closely watched by investors for potential signals about a company's prospects.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Julie Andrews has executed a Power of Attorney appointing several individuals as her attorney-in-fact to prepare, execute, and submit SEC reports, including Forms 3, 4, and 5, and to obtain information regarding company securities. | 02/25/2026 | Facilitates timely and accurate reporting of insider transactions by delegating administrative tasks. |
Stakeholder Impact
- Shareholders: The acquisition by a director may be interpreted as a positive signal of confidence in the company's future performance.
- Management: The filing is a routine disclosure requirement for management and directors.
Key Dates
| Date | Description |
|---|---|
| 02/25/2026 | Date of execution of Power of Attorney by Julie Andrews. |
| 06/17/2026 | Date of transaction (acquisition of common stock) and Date of Grant for RSUs. |
| 06/18/2026 | Date of signature for the Form 4 filing. |
Keywords
Form 4, SEC Filing, Stock Transaction, Director, Beneficial Ownership, RxSight Inc., RXST, Common Stock, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.